血管扩张性休克中血管活性药物的选择与时机
Vasopressor Choice and Timing in Vasodilatory Shock.
作者信息
Wieruszewski Patrick M, Khanna Ashish K
机构信息
Departments of Anesthesiology and Pharmacy, Mayo Clinic, Rochester, MN, USA.
Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
出版信息
Crit Care. 2022 Mar 22;26(1):76. doi: 10.1186/s13054-022-03911-7.
Abstract
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .
摘要
本文是从《2022年重症监护与急诊医学年度更新》中选出的十篇综述之一。其他入选文章可在https://www.biomedcentral.com/collections/annualupdate2022 在线查阅。有关《重症监护与急诊医学年度更新》的更多信息可从https://link.springer.com/bookseries/8901 获取。
相似文献
1
Vasopressor Choice and Timing in Vasodilatory Shock.血管扩张性休克中血管活性药物的选择与时机
Crit Care. 2022 Mar 22;26(1):76. doi: 10.1186/s13054-022-03911-7.
2
Angiotensin in Critical Care.危重病中的血管紧张素。
Crit Care. 2018 Mar 20;22(1):69. doi: 10.1186/s13054-018-1995-z.
3
Advanced Life Support Update.高级生命支持更新。
Crit Care. 2022 Mar 22;26(1):73. doi: 10.1186/s13054-022-03912-6.
4
The Importance of Neuromonitoring in Non Brain Injured Patients.神经监测在非脑损伤患者中的重要性。
Crit Care. 2022 Mar 22;26(1):78. doi: 10.1186/s13054-022-03914-4.
5
Artificial Intelligence in Infection Management in the ICU.人工智能在 ICU 感染管理中的应用。
Crit Care. 2022 Mar 22;26(1):79. doi: 10.1186/s13054-022-03916-2.
6
Artificial Intelligence in Critical Care Medicine.重症医学中的人工智能
Crit Care. 2022 Mar 22;26(1):75. doi: 10.1186/s13054-022-03915-3.
7
The Role of Mitochondria in the Immune Response in Critical Illness.线粒体在危重症免疫反应中的作用
Crit Care. 2022 Mar 22;26(1):80. doi: 10.1186/s13054-022-03908-2.
8
Sepsis Performance Improvement Programs: From Evidence Toward Clinical Implementation.脓毒症绩效改进计划：从证据到临床实施
Crit Care. 2022 Mar 22;26(1):77. doi: 10.1186/s13054-022-03917-1.
9
Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?四环素对危重症患者的免疫调节作用：一种新兴的治疗选择？
Crit Care. 2022 Mar 22;26(1):74. doi: 10.1186/s13054-022-03909-1.
10
Brain Injury Biomarkers for Predicting Outcome After Cardiac Arrest.用于预测心脏骤停后预后的脑损伤生物标志物。
Crit Care. 2022 Mar 22;26(1):81. doi: 10.1186/s13054-022-03913-5.
引用本文的文献
1
A Novel Approach to Early Personalized Hemodynamic Resuscitation: Non-Invasive Peripheral Photoplethysmography for Identifying Predominant Vasodilatory Shock in Sepsis.一种早期个性化血流动力学复苏的新方法：用于识别脓毒症中主要血管舒张性休克的无创外周光电容积描记法。
Acta Anaesthesiol Scand. 2025 Oct;69(9):e70119. doi: 10.1111/aas.70119.
2
Early multimodal vasopressor strategy in septic shock (TRICYCLE)-Study protocol for a randomized controlled clinical trial.脓毒性休克早期多模式血管升压药策略（TRICYCLE）——一项随机对照临床试验的研究方案
PLoS One. 2025 Aug 29;20(8):e0331304. doi: 10.1371/journal.pone.0331304. eCollection 2025.
3
Summary of best evidence for safe management of vasopressors through peripheral intravenous catheters.通过外周静脉导管安全管理血管加压药的最佳证据总结。
BMC Nurs. 2025 Jul 31;24(1):1000. doi: 10.1186/s12912-025-03635-3.
4
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?血管加压素及其类似物在感染性休克患者中的应用：圣杯还是未兑现的承诺？
Crit Care. 2025 Jul 29;29(1):333. doi: 10.1186/s13054-025-05540-2.
5
Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations.去甲肾上腺素药理学：剂量报告的时间顺序回顾及盐制剂的影响
Intensive Care Med. 2025 Sep;51(9):1664-1673. doi: 10.1007/s00134-025-08053-2. Epub 2025 Jul 29.
6
Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents.心脏之外：探索血管活性药物非心血管效应的综述
Front Pharmacol. 2025 Jul 10;16:1533437. doi: 10.3389/fphar.2025.1533437. eCollection 2025.
7
Insights Into the Pathophysiology of Catecholamine-Refractory Shock: A Narrative Review.对儿茶酚胺难治性休克病理生理学的见解：一项叙述性综述
Cureus. 2025 Jun 17;17(6):e86224. doi: 10.7759/cureus.86224. eCollection 2025 Jun.
8
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery.心脏手术后血管麻痹患者血管紧张素 II 给药时机与预后的关系。
JTCVS Open. 2025 Apr 25;25:280-293. doi: 10.1016/j.xjon.2025.04.014. eCollection 2025 Jun.
9
Ascorbic acid and microcirculation in cardiothoracic surgery: a pilot feasibility trial and matched cohort study.抗坏血酸与心胸外科手术中的微循环：一项初步可行性试验及匹配队列研究。
J Cardiothorac Surg. 2025 May 22;20(1):234. doi: 10.1186/s13019-025-03486-8.
10
Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation.早期加用血管加压素对感染性休克患者的影响：一项目标试验模拟研究
Crit Care. 2025 May 12;29(1):188. doi: 10.1186/s13054-025-05401-y.
本文引用的文献
1
Renin Kinetics and Mortality-Same, Same But Different?肾素动力学与死亡率——相同却又不同？
Crit Care Med. 2022 Jan 1;50(1):153-157. doi: 10.1097/CCM.0000000000005157.
2
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动：2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
3
Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.脓毒性休克患者开始使用血管加压素时儿茶酚胺剂量、乳酸水平和休克持续时间与死亡率的关联
Crit Care Med. 2022 Apr 1;50(4):614-623. doi: 10.1097/CCM.0000000000005317.
4
Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients.肾素动力学优于乳酸动力学预测低血压危重症患者住院死亡率。
Crit Care Med. 2022 Jan 1;50(1):50-60. doi: 10.1097/CCM.0000000000005143.
5
Predictors of dysrhythmias with norepinephrine use in septic shock.脓毒性休克中去甲肾上腺素使用与心律失常的预测因素。
J Crit Care. 2021 Feb;61:133-137. doi: 10.1016/j.jcrc.2020.10.023. Epub 2020 Oct 28.
6
Time to vasopressor initiation and organ failure progression in early septic shock.早期脓毒性休克中开始使用血管升压药的时间与器官功能衰竭进展情况
J Am Coll Emerg Physicians Open. 2020 May 2;1(3):222-230. doi: 10.1002/emp2.12060. eCollection 2020 Jun.
7
Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.血管紧张素 II 输注治疗休克：上市后使用的多中心研究。
Chest. 2021 Feb;159(2):596-605. doi: 10.1016/j.chest.2020.08.2074. Epub 2020 Aug 31.
8
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.血管扩张性休克儿茶酚胺抵抗患者应用血管紧张素 II 治疗与肾素及生存关系的临床研究
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1253-1261. doi: 10.1164/rccm.201911-2172OC.
9
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.儿茶酚胺抵抗性血管扩张性休克中的血管紧张素 I 和血管紧张素 II 浓度及其比值。
Crit Care. 2020 Feb 6;24(1):43. doi: 10.1186/s13054-020-2733-x.
10
Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.延迟血管升压药的使用与感染性休克患者死亡率的增加有关。
J Crit Care. 2020 Feb;55:145-148. doi: 10.1016/j.jcrc.2019.11.004. Epub 2019 Nov 9.
Zotero 插件